Whole Blood-plasma-oral Fluid Ratios of Psychoactive Drugs and Medicines
NCT ID: NCT00650130
Last Updated: 2013-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2008-05-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Samples are taken from drivers suspected of being under the influence of drugs or medicines. The samples are analysed with immunological methods and GC-MS.
Observations from Police and a physician on impairment are combined with the results of the different bodily fluids. Observational evaluations and substance concentrations are compared.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
drivers of motorised vehicles suspected of being under the influence of psychoactive drugs
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* driver of a motorised vehicle
Exclusion Criteria
* not the driver of a motorised vehicle
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Helsinki
OTHER
Ministry of Internal Affairs, Finland
UNKNOWN
European Commission
OTHER
Finnish Institute for Health and Welfare
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pirjo Lillsunde, Dr
Role: PRINCIPAL_INVESTIGATOR
National Public Health Institute, Helsinki, Finland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Public Health Institute
Helsinki, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Official home page of the EU-project
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KTL 417-7
Identifier Type: -
Identifier Source: org_study_id